• FOLLOW US
Video Player
  • Email
  • share

Tonix CEO: Investors Seeing Value in Reformulation Strategy

Shares of Tonix Pharmaceuticals are up over 35% in 2014 because investors are finally starting to appreciate the company's story, says Tonix CEO Dr. Seth Lederman. The biotech, which raised $43 million in a January secondary, is working on prescripti

http://www.wgrz.com/video/3216684417001/1/Tonix-CEO-Investors-Seeing-Value-in-Reformulation-Strategy http://cdn.newslook.com/da/da2a47e4fd7aadd445efc28c4fce31fc/images/frame_ext.jpg Tonix CEO: Investors Seeing Value in Reformulation Strategy Shares of Tonix Pharmaceuticals are up over 35% in 2014 because investors are finally starting to appreciate the company's story, says Tonix CEO Dr. Seth Lederman. The biotech, which raised $43 million in a January secondary, is working on prescripti FinanceyoutubeYahoo!newslook 02:51

Next Up

    

More Videos

Recent Videos

Page 1 of 7
Brain Drain Stemmed?

Brain Drain Stemmed?

03:33 | 10/20/2014 9:46:26 PM
Apples Earnings Surpass Expectations

Apple's Earnings Surpass Expectations

01:48 | 10/20/2014 9:15:10 PM
Trailer: Ouija

Trailer: 'Ouija'

02:23 | 10/20/2014 8:17:14 PM
Trailer: Camp X-ray

Trailer: 'Camp X-ray'

02:09 | 10/20/2014 8:16:20 PM
Trailer: John Wick

Trailer: 'John Wick'

01:00 | 10/20/2014 8:16:18 PM